# MITF

## Overview
The MITF gene encodes the melanocyte inducing transcription factor, a pivotal member of the basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factor family. This protein plays a crucial role in the regulation of melanocyte development, differentiation, and survival, primarily by binding to E-box motifs in the promoters of target genes involved in melanin synthesis and other cellular processes (Bertolotto1998Microphthalmia; Kawakami2017The). MITF's activity is modulated by various signaling pathways and post-translational modifications, which influence its stability and function (Goding2019MITF—the). The gene is subject to alternative splicing, resulting in multiple isoforms with distinct functional properties (Goding2019MITF—the). Clinically, mutations in MITF are associated with several genetic disorders, including Waardenburg syndrome and Tietz syndrome, and have implications in melanoma progression and treatment resistance (George2016Biallelic; Oliveira2021Expanding).

## Structure
The microphthalmia-associated transcription factor (MITF) is a member of the basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factor family. Its molecular structure includes a basic domain for DNA binding, a helix-loop-helix motif for dimerization, and a leucine zipper for stability (Goding2019MITF—the). The protein can form homodimers or heterodimers with other members of the MiT-TFE family, such as TFEB, TFE3, and TFEC, facilitated by a specific three-residue sequence in the zipper domain (Vu2020User).

MITF's structure is characterized by a unique three-residue stammer motif within its coiled coil region, which affects dimerization and partner selectivity. This stammer motif induces asymmetry and structural irregularities, particularly in the heptad repeats of the coiled coil segment (Pogenberg2019Mechanism). The presence of the stammer allows MITF to selectively form heterodimers with other bHLH-Zip transcription factors that either contain a stammer or lack any insert (Pogenberg2019Mechanism).

MITF undergoes various post-translational modifications, including phosphorylation, ubiquitination, and sumoylation, which influence its activity and stability (Goding2019MITF—the). The gene's structure allows for alternative splicing, resulting in multiple isoforms that differ in primary sequence and functional properties (Goding2019MITF—the).

## Function
The microphthalmia-associated transcription factor (MITF) is a critical regulator in melanocyte biology, playing a pivotal role in the development, differentiation, and survival of these pigment-producing cells. MITF functions as a transcription factor that binds to E-box motifs in the promoters of target genes, regulating the expression of genes involved in melanin synthesis, such as tyrosinase, TRP1, and TRP2, which are essential for pigmentation (Bertolotto1998Microphthalmia; Kawakami2017The). 

MITF is active in the nucleus, where it influences cell cycle progression and apoptosis by regulating genes like CDK2 and BCL2, contributing to cell proliferation and survival (Kawakami2017The; Levy2011Dual). It also interacts with chromatin remodeling complexes, such as SWI/SNF, to facilitate the transcription of melanocyte-specific genes (de2006The). 

In addition to its role in pigmentation, MITF is involved in the regulation of other cell types, including osteoclasts and mast cells, and is implicated in maintaining cell homeostasis (Kawakami2017The). Its activity is modulated by various signaling pathways, including the cAMP-CREB pathway, which enhances its transcriptional activity in response to external stimuli (Bertolotto1998Microphthalmia).

## Clinical Significance
Mutations in the MITF gene are associated with several genetic disorders and conditions. Biallelic mutations in MITF can lead to a syndrome known as COMMAD, characterized by coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness. These mutations affect the transcriptional regulation of target genes and impair the nuclear localization and DNA-binding ability of MITF, leading to severe phenotypes (George2016Biallelic).

Autosomal-dominant mutations in MITF are linked to Waardenburg syndrome type 2A (WS2A) and Tietz syndrome, both involving deafness and pigmentation disorders. These conditions arise from MITF's role in melanocyte differentiation and survival (Pingault2010Review; Oliveira2021Expanding). A specific mutation, p.E318K, is associated with an increased risk of melanoma, particularly in familial and sporadic cases (Oliveira2021Expanding).

Alterations in MITF expression levels also play a significant role in melanoma progression. High MITF expression is linked to increased proliferation and resistance to chemotherapy, while low levels are associated with reduced proliferation but increased invasiveness (Strub2011Essential). Hypoxia-induced repression of MITF can lead to growth arrest in melanoma cells, suggesting potential therapeutic strategies (Feige2011Hypoxiainduced).

## Interactions
MITF (melanocyte inducing transcription factor) is involved in various protein interactions that influence its function in melanocyte biology and melanoma. It directly interacts with the RAF kinase family, including ARAF, BRAF, and CRAF, with a notable interaction with the BRAF V600E mutant, which is prevalent in melanoma. This interaction is stronger with the activated form of BRAF, suggesting that active RAF kinase forms are required for this interaction (Estrada2022MITF).

MITF also interacts with components of the DNA damage response, particularly the MRN complex, which includes RAD50 and NBS1. These interactions are crucial for modulating DNA repair processes and maintaining genomic stability. The MITF-E318K mutation affects its behavior at DNA damage sites, leading to increased genomic instability (Binet2024DNA).

Additionally, MITF interacts with β-catenin, a key component of the Wnt signaling pathway. This interaction allows MITF to redirect β-catenin's transcriptional activity from Wnt-regulated genes to MITF-specific target promoters, enhancing MITF-dependent gene expression (Schepsky2006The).

MITF's unique leucine zipper structure facilitates selective dimerization with TFE family members, influencing its DNA binding and transcriptional regulation capabilities (Pogenberg2012Restricted).


## References


[1. (George2016Biallelic) Aman George, Dina J. Zand, Robert B. Hufnagel, Ruchi Sharma, Yuri V. Sergeev, Janet M. Legare, Gregory M. Rice, Jessica A. Scott Schwoerer, Mariana Rius, Laura Tetri, David M. Gamm, Kapil Bharti, and Brian P. Brooks. Biallelic mutations in mitf cause coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness. The American Journal of Human Genetics, 99(6):1388–1394, December 2016. URL: http://dx.doi.org/10.1016/j.ajhg.2016.11.004, doi:10.1016/j.ajhg.2016.11.004. This article has 76 citations.](https://doi.org/10.1016/j.ajhg.2016.11.004)

[2. (Schepsky2006The) Alexander Schepsky, Katja Bruser, Gunnar J. Gunnarsson, Jane Goodall, Jón H. Hallsson, Colin R. Goding, Eirikur Steingrimsson, and Andreas Hecht. The microphthalmia-associated transcription factor mitf interacts with β-catenin to determine target gene expression. Molecular and Cellular Biology, 26(23):8914–8927, December 2006. URL: http://dx.doi.org/10.1128/MCB.02299-05, doi:10.1128/mcb.02299-05. This article has 212 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.02299-05)

[3. (Levy2011Dual) Carmit Levy and David E. Fisher. Dual roles of lineage restricted transcription factors: the case of mitf in melanocytes. Transcription, 2(1):19–22, January 2011. URL: http://dx.doi.org/10.4161/trns.2.1.13650, doi:10.4161/trns.2.1.13650. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/trns.2.1.13650)

[4. (Feige2011Hypoxiainduced) Erez Feige, Satoru Yokoyama, Carmit Levy, Mehdi Khaled, Vivien Igras, Richard J. Lin, Stephen Lee, Hans R. Widlund, Scott R. Granter, Andrew L. Kung, and David E. Fisher. Hypoxia-induced transcriptional repression of the melanoma-associated oncogene mitf. Proceedings of the National Academy of Sciences, September 2011. URL: http://dx.doi.org/10.1073/pnas.1106351108, doi:10.1073/pnas.1106351108. This article has 99 citations.](https://doi.org/10.1073/pnas.1106351108)

[5. (Pingault2010Review) Véronique Pingault, Dorothée Ente, Florence Dastot-Le Moal, Michel Goossens, Sandrine Marlin, and Nadège Bondurand. Review and update of mutations causing waardenburg syndrome. Human Mutation, 31(4):391–406, February 2010. URL: http://dx.doi.org/10.1002/humu.21211, doi:10.1002/humu.21211. This article has 445 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21211)

[6. (de2006The) Ivana L. de la Serna, Yasuyuki Ohkawa, Chiduru Higashi, Chaitali Dutta, Jules Osias, Naveen Kommajosyula, Taro Tachibana, and Anthony N. Imbalzano. The microphthalmia-associated transcription factor requires swi/snf enzymes to activate melanocyte-specific genes. Journal of Biological Chemistry, 281(29):20233–20241, July 2006. URL: http://dx.doi.org/10.1074/jbc.M512052200, doi:10.1074/jbc.m512052200. This article has 125 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M512052200)

[7. (Goding2019MITF—the) Colin R. Goding and Heinz Arnheiter. Mitf—the first 25 years. Genes &amp; Development, 33(15–16):983–1007, May 2019. URL: http://dx.doi.org/10.1101/gad.324657.119, doi:10.1101/gad.324657.119. This article has 279 citations.](https://doi.org/10.1101/gad.324657.119)

[8. (Bertolotto1998Microphthalmia) Corine Bertolotto, Patricia Abbe, Timothy J. Hemesath, Karine Bille, David E. Fisher, Jean-Paul Ortonne, and Robert Ballotti. Microphthalmia gene product as a signal transducer in camp-induced differentiation of melanocytes. The Journal of Cell Biology, 142(3):827–835, August 1998. URL: http://dx.doi.org/10.1083/jcb.142.3.827, doi:10.1083/jcb.142.3.827. This article has 422 citations.](https://doi.org/10.1083/jcb.142.3.827)

[9. (Strub2011Essential) T Strub, S Giuliano, T Ye, C Bonet, C Keime, D Kobi, S Le Gras, M Cormont, R Ballotti, C Bertolotto, and I Davidson. Essential role of microphthalmia transcription factor for dna replication, mitosis and genomic stability in melanoma. Oncogene, 30(20):2319–2332, January 2011. URL: http://dx.doi.org/10.1038/onc.2010.612, doi:10.1038/onc.2010.612. This article has 212 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2010.612)

[10. (Binet2024DNA) Romuald Binet, Jean-Philippe Lambert, Marketa Tomkova, Samuel Tischfield, Arianna Baggiolini, Sarah Picaud, Sovan Sarkar, Pakavarin Louphrasitthiphol, Diogo Dias, Suzanne Carreira, Timothy C. Humphrey, Panagis Fillipakopoulos, Richard White, and Colin R. Goding. Dna damage remodels the mitf interactome to increase melanoma genomic instability. Genes &amp; Development, 38(1–2):70–94, January 2024. URL: http://dx.doi.org/10.1101/gad.350740.123, doi:10.1101/gad.350740.123. This article has 1 citations.](https://doi.org/10.1101/gad.350740.123)

[11. (Estrada2022MITF) Charlène Estrada, Liliana Mirabal-Ortega, Laurence Méry, Florent Dingli, Laetitia Besse, Cedric Messaoudi, Damarys Loew, Celio Pouponnot, Corine Bertolotto, Alain Eychène, and Sabine Druillennec. Mitf activity is regulated by a direct interaction with raf proteins in melanoma cells. Communications Biology, January 2022. URL: http://dx.doi.org/10.1038/s42003-022-03049-w, doi:10.1038/s42003-022-03049-w. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-022-03049-w)

[12. (Pogenberg2012Restricted) Vivian Pogenberg, Margrét H Ögmundsdóttir, Kristín Bergsteinsdóttir, Alexander Schepsky, Bengt Phung, Viktor Deineko, Morlin Milewski, Eiríkur Steingrímsson, and Matthias Wilmanns. Restricted leucine zipper dimerization and specificity of dna recognition of the melanocyte master regulator mitf. Genes &amp; Development, 26(23):2647–2658, December 2012. URL: http://dx.doi.org/10.1101/gad.198192.112, doi:10.1101/gad.198192.112. This article has 104 citations.](https://doi.org/10.1101/gad.198192.112)

[13. (Pogenberg2019Mechanism) Vivian Pogenberg, Josué Ballesteros-Álvarez, Romana Schober, Ingibjörg Sigvaldadóttir, Agnieszka Obarska-Kosinska, Morlin Milewski, Rainer Schindl, Margrét Helga Ögmundsdóttir, Eiríkur Steingrímsson, and Matthias Wilmanns. Mechanism of conditional partner selectivity in mitf/tfe family transcription factors with a conserved coiled coil stammer motif. Nucleic Acids Research, 48(2):934–948, November 2019. URL: http://dx.doi.org/10.1093/nar/gkz1104, doi:10.1093/nar/gkz1104. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkz1104)

[14. (Oliveira2021Expanding) Leandro Jonata Carvalho Oliveira, Aline Bobato Lara Gongora, Fabiola Ambrosio Silveira Lima, Felipe Sales Nogueira Amorim Canedo, Carla Vanessa Quirino, Janina Pontes Pisani, Maria Isabel Achatz, and Benedito Mauro Rossi. Expanding the phenotype of e318k (c.952g &gt; a) mitf germline mutation carriers: case series and review of the literature. Hereditary Cancer in Clinical Practice, July 2021. URL: http://dx.doi.org/10.1186/s13053-021-00189-8, doi:10.1186/s13053-021-00189-8. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13053-021-00189-8)

[15. (Kawakami2017The) Akinori Kawakami and David E Fisher. The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology. Laboratory Investigation, 97(6):649–656, June 2017. URL: http://dx.doi.org/10.1038/labinvest.2017.9, doi:10.1038/labinvest.2017.9. This article has 212 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/labinvest.2017.9)

[16. (Vu2020User) Hong Nhung Vu, Ramile Dilshat, Valerie Fock, and Eiríkur Steingrímsson. User guide to mit‐tfe isoforms and post‐translational modifications. Pigment Cell &amp; Melanoma Research, 34(1):13–27, September 2020. URL: http://dx.doi.org/10.1111/pcmr.12922, doi:10.1111/pcmr.12922. This article has 14 citations.](https://doi.org/10.1111/pcmr.12922)